NicholasGTulloMDFACC, FHRS

PubMed

• 23 citations
  Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
  Anne B. Curtis, A. Allen Seals, Robert E. Safford, William Slater, Nicholas G. Tullo, Humberto Vidaillet, David J. Wilber, April Slee> ;American Heart Journal. 2005 Feb 1
• 1 citations
  Factors determining ICD implantation in drug therapy patients after termination of antiarrythmics versus implantable defibrillators trial.
  Richard C. Klein, Eleanor Schron, Ellen Graham Renfroe, Al Hallstrom, Jack Kron, Celeste Ocampo, Anna O Leonen, Nicholas G. Tullo, Avid Investigators> ;Pacing and Clinical Electrophysiology. 2003 Dec 1
• 23 citations
  Natural history and predictors of temporary epicardial pacemaker wire function in patients after open heart surgery.
  Farhad Elmi, Nicholas G. Tullo, Koroush Khalighi> ;Cardiology. 2002 Jan 1
• 46 citations
  Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study
  Jonathan S. Steinberg, James B. Martins, Saihari Sadanandan, Bruce G. Goldner, Edith Menchavez, Michael J. Domanski, Andrea M. Russo, Nicholas G. Tullo, Al Hallstrom> ;American Heart Journal. 2001 Sep 1
• 34 citations
  Clinical characteristics of patients intolerant to VVIR pacing.
  Kenneth A. Ellenbogen, Bruce S. Stambler, E. John Orav, Elena B. Sgarbossa, Nicholas G. Tullo, Charles A Love, Mark A. Wood, Lee Goldman, Gervasio A. Lamas> ;The American Journal of Cardiology. 2000 Jul 1
• Catheter ablation of the slow AV nodal pathway in AV nodal re-entry tachycardia.
  Khalighi, K., Tullo, N. G., Haft, J. I.> ;N J Med. 1994 Feb
• Accurate bedside technique for differentiating wide-QRS complex tachycardias.
  Ezeugwu, C. O., Tullo, N. G.> ;N J Med. 1993 Oct
• A randomized comparative study of the electrophysiological and electrocardiographic effects of isradipine vs verapamil.
  Tullo, N. G., Landau, S., Goldman, I., Coutinho, N., Somberg, J.> ;Acta Anaesthesiol Scand Suppl. 1993
• 58 citations
  Experience with a third-generation implantable cardioverter-defibrillator.
  Sanjeev Saksena, Davendra Mehta, Ryszard B. Krol, Nicholas G. Tullo, Amarkanth Saxena, Raj R. Kaushik, John Neglia> ;The American Journal of Cardiology. 1991 Jun 15
• 52 citations
  Management of complications associated with a first-generation endocardial defibrillation lead system for implantable cardioverter-defibrillators.
  Nicholas G. Tullo, Sanjeev Saksena, Ryszard B. Krol, Ann Marie P. Mauro, Denise Kunecz> ;The American Journal of Cardiology. 1990 Aug 15
• 19 citations
  Argon laser ablation of malignant ventricular tachycardia associated with coronary artery disease.
  Sanjeev Saksena, Isaac Gielchinsky, Nicholas G. Tullo> ;The American Journal of Cardiology. 1989 Dec 1
• 71 citations
  Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
  Sanjeev Saksena, Nicholas G. Tullo, Ryszard B. Krol, Ann Marie P. Mauro> ;Archives of Internal Medicine. 1989 Oct 1
• Join now to see all

Abstracts/Posters

• Optimal Implant Depth for Insertable Cardiac Monitors
  Tullo, N, Heart Rhythm, Heart Rhythm Society Annual Scientific Session, San Francisco, 5/7/2014